Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Frontiers in Oncology|June 17, 2022
Application of a Novel <sup>68</sup>Ga-HER2 Affibody PET/CT Imaging in Breast Cancer PatientsHaitao Miao, Yuyun Sun, Yizi Jin, et al.Journal of Diabetes|March 9, 2019
Prognosis for residual islet β-cell secretion function in young patients with newly diagnosed type 1 diabetesHaitao Miao, Juanjuan Zhang, Bin Gu, et al.Journal of Environmental Management|December 23, 2023
Appropriate livestock grazing alleviates the loss of plant diversity and maintains community resistance in alpine meadowsXiaofang Wang, Zaiwei Wang, Haitao Miao, et al.Journal of Biomedical Nanotechnology|January 3, 2022
Self-Assembly Cascade Reaction Platform for CD44 Positive Lung Cancer TherapyHaitao Miao, Xiaoxiao Zhu, Fei Yuan, et al.Quantitative Imaging in Medicine and Surgery|December 19, 2024
Quantitative observation based on magnetic resonance imaging: the effects of marathon running on lumbar vertebrae, paraspinal muscles, and lumbar disc componentsJiahui Li, Xiaolong Deng, Boyi Li, et al.Scientific Reports|February 7, 2018
Characterizations of distinct parallel and antiparallel G-quadruplexes formed by two-repeat ALS and FTD related GGGGCC sequenceBo Zhou, Yanyan Geng, Changdong Liu, et al.Annals of Palliative Medicine|October 21, 2021
Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancerYanchun Meng, Juan Jin, Chengcheng Gong, et al.Nucleic Acids Research|April 9, 2019
The crystal structure of an antiparallel chair-type G-quadruplex formed by Bromo-substituted human telomeric DNAYanyan Geng, Changdong Liu, Bo Zhou, et al.Nucleic Acids Research|June 11, 2024
Crystal structure of a tetrameric RNA G-quadruplex formed by hexanucleotide repeat expansions of C9orf72 in ALS/FTDYanyan Geng, Changdong Liu, Naining Xu, et al.Eclinicalmedicine|November 17, 2025
Efficacy and safety of ARX788 for individuals with HER2-positive breast cancer and brain metastases (ACE-Breast-06): a single-arm, phase 2 trial in ChinaTing Li, Mingxi Lin, Biyun Wang, et al.Pageof 2